NCT06761131View on ClinicalTrials.gov

Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

May 20, 2025

Study Completion Date

June 20, 2025

Conditions

ThrombocytopaeniaImpaired Renal Function

Interventions

DRUG

Linezolid (LZD)

compare the incidence and magnitude of Linezolid induced thrombocytopenia

Trial Locations (1)

Unknown

Ain Shams University Hospitals, Cairo

All Listed Sponsors

lead

Ain Shams University

OTHER

NCT06761131 - Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function | Biotech Hunter | Biotech Hunter